Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Global PC market grew 11.2% y/y in Q2, says IDC » 17:46
07/09/20
07/09
17:46
07/09/20
17:46
HPQ

HP Inc.

$16.41 /

-0.35 (-2.09%)

, LNVGY

Lenovo

$0.00 /

+ (+0.00%)

, DELL

Dell Technologies

$53.73 /

-0.41 (-0.76%)

, AAPL

Apple

$382.78 /

+1.49 (+0.39%)

, MU

Micron

$49.99 /

+0.28 (+0.56%)

, WDC

Western Digital

$42.34 /

-0.45 (-1.05%)

, MSFT

Microsoft

$214.40 /

+1.51 (+0.71%)

, GOOG

Alphabet

$1,510.25 /

+14.22 (+0.95%)

, GOOGL

Alphabet Class A

$1,516.71 /

+14.12 (+0.94%)

, STX

Seagate

$46.79 /

+0.23 (+0.49%)

, QCOM

Qualcomm

$93.24 /

-0.29 (-0.31%)

, INTC

Intel

$58.43 /

-0.2 (-0.34%)

, IBM

IBM

$115.63 /

-2.09 (-1.78%)

, NTAP

NetApp

$42.29 /

-1 (-2.31%)

The second quarter of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WDC Western Digital
$42.34 /

-0.45 (-1.05%)

STX Seagate
$46.79 /

+0.23 (+0.49%)

QCOM Qualcomm
$93.24 /

-0.29 (-0.31%)

NTAP NetApp
$42.29 /

-1 (-2.31%)

MU Micron
$49.99 /

+0.28 (+0.56%)

MSFT Microsoft
$214.40 /

+1.51 (+0.71%)

LNVGY Lenovo
$0.00 /

+ (+0.00%)

INTC Intel
$58.43 /

-0.2 (-0.34%)

IBM IBM
$115.63 /

-2.09 (-1.78%)

HPQ HP Inc.
$16.41 /

-0.35 (-2.09%)

GOOG Alphabet
$1,510.25 /

+14.22 (+0.95%)

DELL Dell Technologies
$53.73 /

-0.41 (-0.76%)

AAPL Apple
$382.78 /

+1.49 (+0.39%)

HPQ HP Inc.
$16.41 /

-0.35 (-2.09%)

06/30/20 Cowen
HP Inc. initiated with a Market Perform at Cowen
05/28/20
Fly Intel: Top five analyst downgrades
05/28/20 JPMorgan
HP Inc. downgraded to Neutral from Overweight at JPMorgan
05/26/20 Credit Suisse
HP Inc. price target lowered to $17 from $22 at Credit Suisse
LNVGY Lenovo
$0.00 /

+ (+0.00%)

05/21/20 JPMorgan
Lenovo downgraded to Neutral from Overweight at JPMorgan
03/27/20 Goldman Sachs
Lenovo downgraded to Neutral from Buy at Goldman Sachs
DELL Dell Technologies
$53.73 /

-0.41 (-0.76%)

10:11 Today
Fly Intel: Top five analyst initiations
06:15 Today Daiwa
Dell Technologies initiated with a Neutral at Daiwa
07/07/20 Deutsche Bank
Dell offers 20%-30% upside on standalone basis, says Deutsche Bank
06/30/20 Cowen
Dell Technologies initiated with a Market Perform at Cowen
AAPL Apple
$382.78 /

+1.49 (+0.39%)

15:31 Today Nomura Instinet
Nomura says Apple iPhone shipments in China pressured by 5G models in June
07/08/20 Deutsche Bank
'Nervous' Deutsche Bank raises Apple price target to $400 from $380
07/07/20 Raymond James
Apple price target raised to $400 from $340 at Raymond James
07/06/20 Loop Capital
Apple's build plan update negates speculation of cut, says Loop Capital
MU Micron
$49.99 /

+0.28 (+0.56%)

06/30/20 RBC Capital
Micron price target raised to $60 from $55 at RBC Capital
06/30/20 Morgan Stanley
Morgan Stanley would add to Micron positions on weakness in coming 'rough patch'
06/30/20 Raymond James
Micron price target raised to $65 from $60 at Raymond James
06/30/20 Mizuho
Micron price target raised to $63 from $60 at Mizuho
WDC Western Digital
$42.34 /

-0.45 (-1.05%)

06/30/20 Benchmark
Micron report and guidance 'bode well' for Western Digital, says Benchmark
06/26/20 KeyBanc
Memory supply remains limited in 2H amid low visibility, says KeyBanc
06/22/20 Benchmark
Western Digital upgraded to Buy from Hold at Benchmark
06/19/20 Benchmark
Benchmark says Samsung's NAND chip issues likely positive for HDD makers
MSFT Microsoft
$214.40 /

+1.51 (+0.71%)

08:53 Today Morgan Stanley
Microsoft price target raised to $230 from $198 at Morgan Stanley
08:06 Today Wedbush
Microsoft price target raised to $260 from $220 at Wedbush
07/07/20 Loop Capital
Logitech price target raised to $78 from $58 at Loop Capital
07/06/20 Morgan Stanley
Microsoft skilling focus tempers some Pluralsight optimism, says Morgan Stanley
GOOG Alphabet
$1,510.25 /

+14.22 (+0.95%)

08:15 Today Wedbush
Pinterest price target raised to $31 from $26 at Wedbush
07/07/20 BofA
Potential U.S. ban of TikTok could be tailwind to Snap engagement, says BofA
06/29/20 Stifel
Stifel says Facebook sales won't be materially hurt unless ad boycott broadens
06/25/20 Baird
Alphabet price target raised to $1,650 from $1,500 at Baird
GOOGL Alphabet Class A
$1,516.71 /

+14.12 (+0.94%)

STX Seagate
$46.79 /

+0.23 (+0.49%)

06/08/20 Rosenblatt
Rosenblatt starts Western Digital at Neutral, sees technology lagging Seagate
06/08/20 Rosenblatt
Rosenblatt starts Seagate at Buy, sees technology lead over Western Digital
06/08/20 Rosenblatt
Seagate initiated with a Buy at Rosenblatt
QCOM Qualcomm
$93.24 /

-0.29 (-0.31%)

07/01/20 BofA
BofA makes 14 additions, four deletions from US 1 list
06/16/20
Fly Intel: Top five analyst upgrades
06/16/20 Morgan Stanley
Qualcomm upgraded to Overweight on improving smartphone demand at Morgan Stanley
06/16/20 Morgan Stanley
Qualcomm upgraded to Overweight from Equal Weight at Morgan Stanley
INTC Intel
$58.43 /

-0.2 (-0.34%)

07/07/20 William Blair
William Blair says trends helping MaxLinear likely boosting unit being bought
07/06/20
Fly Intel: Top five analyst downgrades
07/06/20 Goldman Sachs
Intel downgraded to Sell from Neutral at Goldman Sachs
IBM IBM
$115.63 /

-2.09 (-1.78%)

07/08/20 Stifel
IBM consensus for second half, 2021 appears 'reasonable,' says Stifel
06/09/20 DA Davidson
DA Davidson says Cloudera sale 'increasingly likely,' IBM seen as possible buyer
04/21/20 Morgan Stanley
Krishna years away from returning IBM to sustainable growth, says Morgan Stanley
04/21/20 Wedbush
IBM price target lowered to $140 from $155 at Wedbush
NTAP NetApp
$42.29 /

-1 (-2.31%)

06/26/20
Fly Intel: Top five analyst upgrades
06/26/20 BofA
NetApp upgraded to Buy from Neutral at BofA
06/26/20 BofA
NetApp upgraded to Buy from Neutral at BofA
06/18/20 Deutsche Bank
NetApp initiated with a Hold at Deutsche Bank
WDC Western Digital
$42.34 /

-0.45 (-1.05%)

STX Seagate
$46.79 /

+0.23 (+0.49%)

QCOM Qualcomm
$93.24 /

-0.29 (-0.31%)

NTAP NetApp
$42.29 /

-1 (-2.31%)

MU Micron
$49.99 /

+0.28 (+0.56%)

MSFT Microsoft
$214.40 /

+1.51 (+0.71%)

INTC Intel
$58.43 /

-0.2 (-0.34%)

IBM IBM
$115.63 /

-2.09 (-1.78%)

HPQ HP Inc.
$16.41 /

-0.35 (-2.09%)

GOOG Alphabet
$1,510.25 /

+14.22 (+0.95%)

DELL Dell Technologies
$53.73 /

-0.41 (-0.76%)

AAPL Apple
$382.78 /

+1.49 (+0.39%)

WDC Western Digital
$42.34 /

-0.45 (-1.05%)

STX Seagate
$46.79 /

+0.23 (+0.49%)

QCOM Qualcomm
$93.24 /

-0.29 (-0.31%)

MU Micron
$49.99 /

+0.28 (+0.56%)

MSFT Microsoft
$214.40 /

+1.51 (+0.71%)

LNVGY Lenovo
$0.00 /

+ (+0.00%)

INTC Intel
$58.43 /

-0.2 (-0.34%)

IBM IBM
$115.63 /

-2.09 (-1.78%)

HPQ HP Inc.
$16.41 /

-0.35 (-2.09%)

GOOG Alphabet
$1,510.25 /

+14.22 (+0.95%)

DELL Dell Technologies
$53.73 /

-0.41 (-0.76%)

AAPL Apple
$382.78 /

+1.49 (+0.39%)

WDC Western Digital
$42.34 /

-0.45 (-1.05%)

STX Seagate
$46.79 /

+0.23 (+0.49%)

QCOM Qualcomm
$93.24 /

-0.29 (-0.31%)

NTAP NetApp
$42.29 /

-1 (-2.31%)

MU Micron
$49.99 /

+0.28 (+0.56%)

MSFT Microsoft
$214.40 /

+1.51 (+0.71%)

INTC Intel
$58.43 /

-0.2 (-0.34%)

IBM IBM
$115.63 /

-2.09 (-1.78%)

HPQ HP Inc.
$16.41 /

-0.35 (-2.09%)

GOOG Alphabet
$1,510.25 /

+14.22 (+0.95%)

DELL Dell Technologies
$53.73 /

-0.41 (-0.76%)

AAPL Apple
$382.78 /

+1.49 (+0.39%)

WDC Western Digital
$42.34 /

-0.45 (-1.05%)

STX Seagate
$46.79 /

+0.23 (+0.49%)

QCOM Qualcomm
$93.24 /

-0.29 (-0.31%)

NTAP NetApp
$42.29 /

-1 (-2.31%)

MU Micron
$49.99 /

+0.28 (+0.56%)

MSFT Microsoft
$214.40 /

+1.51 (+0.71%)

INTC Intel
$58.43 /

-0.2 (-0.34%)

IBM IBM
$115.63 /

-2.09 (-1.78%)

HPQ HP Inc.
$16.41 /

-0.35 (-2.09%)

GOOGL Alphabet Class A
$1,516.71 /

+14.12 (+0.94%)

GOOG Alphabet
$1,510.25 /

+14.22 (+0.95%)

DELL Dell Technologies
$53.73 /

-0.41 (-0.76%)

AAPL Apple
$382.78 /

+1.49 (+0.39%)

INTC Intel
$58.43 /

-0.2 (-0.34%)

GOOG Alphabet
$1,510.25 /

+14.22 (+0.95%)

AAPL Apple
$382.78 /

+1.49 (+0.39%)

Conference/Events
NetApp participates in a conference call hosted by Susquehanna » 15:55
07/09/20
07/09
15:55
07/09/20
15:55
NTAP

NetApp

$42.58 /

-0.71 (-1.64%)

Susquehanna Technology…

Susquehanna Technology Analyst Hosseini holds a conference call with CFO Berry on July 9 at 4 pm.

ShowHide Related Items >><<
NTAP NetApp
$42.58 /

-0.71 (-1.64%)

NTAP NetApp
$42.58 /

-0.71 (-1.64%)

06/26/20
Fly Intel: Top five analyst upgrades
06/26/20 BofA
NetApp upgraded to Buy from Neutral at BofA
06/26/20 BofA
NetApp upgraded to Buy from Neutral at BofA
06/18/20 Deutsche Bank
NetApp initiated with a Hold at Deutsche Bank
NTAP NetApp
$42.58 /

-0.71 (-1.64%)

NTAP NetApp
$42.58 /

-0.71 (-1.64%)

NTAP NetApp
$42.58 /

-0.71 (-1.64%)

NTAP NetApp
$42.58 /

-0.71 (-1.64%)

Hot Stocks
Pfizer pledges $100M to new Antimicrobial Resistance Action Fund » 15:23
07/09/20
07/09
15:23
07/09/20
15:23
PFE

Pfizer

$33.57 /

-0.19 (-0.56%)

, AMGN

Amgen

$252.34 /

+0.74 (+0.29%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, LLY

Eli Lilly

$166.59 /

-2.52 (-1.49%)

, GSK

GlaxoSmithKline

$40.37 /

-0.35 (-0.86%)

, MRK

Merck

$76.99 /

-0.88 (-1.13%)

, MKGAY

Merck KGaA

$0.00 /

+ (+0.00%)

, TEVA

Teva

$11.60 /

+0.21 (+1.84%)

, TAK

Takeda Pharmaceutical

$17.36 /

-0.135 (-0.77%)

, NVO

Novo Nordisk

$65.63 /

-0.23 (-0.35%)

, JNJ

Johnson & Johnson

$143.03 /

-0.21 (-0.15%)

, NVS

Novartis

$87.53 /

-0.585 (-0.66%)

Pfizer (PFE) announced…

Pfizer (PFE) announced earlier it has pledged $100M to the new Antimicrobial Resistance, or "AMR," Action Fund, which launched today, to help address the significant global public health need for new antibiotics due to the rapid rise of antibiotic-resistant infections. "The AMR Action Fund is a ground-breaking collaboration among more than 20 biopharmaceutical companies that aims to bring 2-4 new antibiotics to patients by 2030 through collaboration between pharmaceutical companies, philanthropies, development banks, and multilateral organizations to re-invigorate and accelerate antibiotic development," the company stated. "As the COVID-19 pandemic has shown, we must invest in the development of medicines now so that we are prepared to help prevent the next public health crisis," added Pfizer Chairman and CEO Albert Bourla. Other investors in the AMR Action Fund include Amgen (AMGN), Bayer (BAYRY), Roche (RHHBY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Merck (MRK), Merck KGaA (MKGAY), Teva (TEVA), Takeda Pharmaceutical (TAK), Novo Nordisk (NVO), Johnson & Johnson (JNJ) and Novartis (NVS). Reference Link

ShowHide Related Items >><<
TEVA Teva
$11.60 /

+0.21 (+1.84%)

TAK Takeda Pharmaceutical
$17.36 /

-0.135 (-0.77%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$33.57 /

-0.19 (-0.56%)

NVS Novartis
$87.53 /

-0.585 (-0.66%)

NVO Novo Nordisk
$65.63 /

-0.23 (-0.35%)

MRK Merck
$76.99 /

-0.88 (-1.13%)

MKGAY Merck KGaA
$0.00 /

+ (+0.00%)

LLY Eli Lilly
$166.59 /

-2.52 (-1.49%)

JNJ Johnson & Johnson
$143.03 /

-0.21 (-0.15%)

GSK GlaxoSmithKline
$40.37 /

-0.35 (-0.86%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AMGN Amgen
$252.34 /

+0.74 (+0.29%)

PFE Pfizer
$33.57 /

-0.19 (-0.56%)

07/08/20 Piper Sandler
Opko Health price target raised to $6 from $4 at Piper Sandler
07/08/20 Argus
Pfizer positioned for stronger revenue growth in 2021 and beyond, says Argus
07/07/20 Needham
Vaxcyte initiated with a Buy at Needham
07/02/20 B. Riley FBR
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR
AMGN Amgen
$252.34 /

+0.74 (+0.29%)

07/02/20 Citi
Citi sees 'considerable amount of investor interest' coming back to Amgen
07/01/20 Piper Sandler
Amgen appeal rules in favor of patent validity, says Piper Sandler
07/01/20 Mizuho
Amgen patent win worth $5-$12 per share, says Mizuho
07/01/20 Goldman Sachs
Court ruling removes overhang for Amgen, says Goldman Sachs
BAYRY Bayer
$0.00 /

+ (+0.00%)

06/26/20 JPMorgan
Bayer price target raised to EUR 77 from EUR 75 at JPMorgan
06/26/20 Deutsche Bank
Bayer price target raised to EUR 87 from EUR 85 at Deutsche Bank
06/25/20 Morgan Stanley
Bayer price target raised to EUR 88 from EUR 83 at Morgan Stanley
06/25/20 HSBC
HSBC upgrades Bayer to Buy after settlement on most Monsanto cases in U.S.
RHHBY Roche
$0.00 /

+ (+0.00%)

07/03/20 AlphaValue
Roche upgraded to Add from Reduce at AlphaValue
06/29/20 Piper Sandler
Herceptin/Perjecta approval another win for Halozyme, says Piper
06/23/20 Guggenheim
Immunomedics could be M&A fit for several large-cap drugmakers, says Guggenheim
06/10/20 SunTrust
Arcus Biosciences price target raised to $45 from $22 at SunTrust
LLY Eli Lilly
$166.59 /

-2.52 (-1.49%)

10:13 Today Morgan Stanley
Eli Lilly won't publish Phase 1 COVID antibody data, says Morgan Stanley
06/29/20 Mizuho
Eli Lilly price target raised to $164 from $155 at Mizuho
06/17/20 JPMorgan
Eli Lilly price target raised to $190 from $175 at JPMorgan
GSK GlaxoSmithKline
$40.37 /

-0.35 (-0.86%)

06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
06/19/20 Barclays
Glaxo belantamab AdCom a surprise, supports cautious view, says Barclays
06/16/20 Roth Capital
Ideaya Biosciences price target raised to $23 from $12 at Roth Capital
05/14/20 UBS
GlaxoSmithKline price target raised to 1,920 GBp from 1,900 GBp at UBS
MRK Merck
$76.99 /

-0.88 (-1.13%)

06/30/20 SVB Leerink
Seattle Genetics price target raised to $167 from $155 at SVB Leerink
06/30/20 Oppenheimer
Seattle Genetics price target raised to $210 from $200 at Oppenheimer
06/25/20 Lake Street
Lake Street says Keytruda approval improves outlook for Checkpoint's cosibelimab
MKGAY Merck KGaA
$0.00 /

+ (+0.00%)

05/15/20 Nord/LB
Merck KGaA downgraded to Hold from Buy at Nord/LB
03/06/20 UBS
UBS backs Neutral on Merck KGaA after Q4 results
12/02/19 Goldman Sachs
Merck KGaA reinstated with a Sell at Goldman Sachs
10/04/19 Loop Capital
Entegris price target raised to $51 from $47 at Loop Capital
TEVA Teva
$11.60 /

+0.21 (+1.84%)

07/02/20 Wells Fargo
Emergent BioSolutions price target raised to $93 from $85 at Wells Fargo
06/26/20 William Blair
Pfenex partner CHMP opinion 'material de-risking event,' says William Blair
06/17/20 Stifel
Amarin settlement with Apotex an 'incremental positive,' says Stifel
06/08/20 Guggenheim
Emergent BioSolutions price target lowered to $87 from $101 at Guggenheim
TAK Takeda Pharmaceutical
$17.36 /

-0.135 (-0.77%)

06/18/20 RBC Capital
Neurocrine price target raised to $135 from $116 at RBC Capital
06/17/20 Oppenheimer
Takeda deal expands Neurocrine's pipeline into psychiatry, says Oppenheimer
04/20/20 SVB Leerink
Ascendis Pharma price target raised to $170 from $152 at SVB Leerink
03/25/20 Piper Sandler
Piper Sandler backs Overweight on 'well capitalized' Exelixis
NVO Novo Nordisk
$65.63 /

-0.23 (-0.35%)

07/06/20 BofA
Novo Nordisk downgraded to Neutral from Buy at BofA
06/05/20 JPMorgan
JPMorgan backs Overweight on Novo Nordisk after STEP data
05/18/20 Morgan Stanley
Novo Nordisk price target raised to DKK 435 from DKK 425 at Morgan Stanley
05/13/20 JPMorgan
Novo Nordisk price target raised to DKK 480 from DKK 460 at JPMorgan
JNJ Johnson & Johnson
$143.03 /

-0.21 (-0.15%)

07/06/20 Baird
Cooper Companies downgraded to Neutral, Baird see confluence of issues
07/01/20 JMP Securities
Minerva's seltorexant still 'underappreciated' upside driver, says JMP
05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
NVS Novartis
$87.53 /

-0.585 (-0.66%)

07/01/20 Jefferies
Amgen win on Enbrel patent removes key overhang, says Jefferies
07/01/20 Goldman Sachs
Global Blood Therapeutics upgraded to Buy from Neutral at Goldman Sachs
06/24/20 Morgan Stanley
Novartis' syringe suit not a material threat to Regeneron, says Morgan Stanley
TEVA Teva
$11.60 /

+0.21 (+1.84%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$33.57 /

-0.19 (-0.56%)

NVS Novartis
$87.53 /

-0.585 (-0.66%)

NVO Novo Nordisk
$65.63 /

-0.23 (-0.35%)

MRK Merck
$76.99 /

-0.88 (-1.13%)

LLY Eli Lilly
$166.59 /

-2.52 (-1.49%)

JNJ Johnson & Johnson
$143.03 /

-0.21 (-0.15%)

GSK GlaxoSmithKline
$40.37 /

-0.35 (-0.86%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AMGN Amgen
$252.34 /

+0.74 (+0.29%)

TEVA Teva
$11.60 /

+0.21 (+1.84%)

TAK Takeda Pharmaceutical
$17.36 /

-0.135 (-0.77%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$33.57 /

-0.19 (-0.56%)

NVO Novo Nordisk
$65.63 /

-0.23 (-0.35%)

MRK Merck
$76.99 /

-0.88 (-1.13%)

MKGAY Merck KGaA
$0.00 /

+ (+0.00%)

LLY Eli Lilly
$166.59 /

-2.52 (-1.49%)

JNJ Johnson & Johnson
$143.03 /

-0.21 (-0.15%)

GSK GlaxoSmithKline
$40.37 /

-0.35 (-0.86%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AMGN Amgen
$252.34 /

+0.74 (+0.29%)

TEVA Teva
$11.60 /

+0.21 (+1.84%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$33.57 /

-0.19 (-0.56%)

NVS Novartis
$87.53 /

-0.585 (-0.66%)

NVO Novo Nordisk
$65.63 /

-0.23 (-0.35%)

MRK Merck
$76.99 /

-0.88 (-1.13%)

LLY Eli Lilly
$166.59 /

-2.52 (-1.49%)

JNJ Johnson & Johnson
$143.03 /

-0.21 (-0.15%)

GSK GlaxoSmithKline
$40.37 /

-0.35 (-0.86%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AMGN Amgen
$252.34 /

+0.74 (+0.29%)

TEVA Teva
$11.60 /

+0.21 (+1.84%)

TAK Takeda Pharmaceutical
$17.36 /

-0.135 (-0.77%)

PFE Pfizer
$33.57 /

-0.19 (-0.56%)

NVS Novartis
$87.53 /

-0.585 (-0.66%)

MRK Merck
$76.99 /

-0.88 (-1.13%)

LLY Eli Lilly
$166.59 /

-2.52 (-1.49%)

JNJ Johnson & Johnson
$143.03 /

-0.21 (-0.15%)

GSK GlaxoSmithKline
$40.37 /

-0.35 (-0.86%)

AMGN Amgen
$252.34 /

+0.74 (+0.29%)

Hot Stocks
Abeona Therapeutics appoints Michael Amoroso as CCO » 07:36
07/09/20
07/09
07:36
07/09/20
07:36
ABEO

Abeona Therapeutics

$3.42 /

+0.025 (+0.74%)

, GILD

Gilead

$75.63 /

-0.84 (-1.10%)

Abeona Therapeutics…

Abeona Therapeutics (ABEO) announced the appointment of Michael Amoroso as senior VP and chief commercial officer, or CCO, effective immediately. Amoroso brings to Abeona over 20 years of product commercialization experience in the biotechnology and pharmaceutical industries, most recently as senior VP and head of worldwide commercial, cell therapy at Kite, a Gilead company (GILD). Amoroso will have overall responsibility for building the company's commercial organization, developing the commercialization strategy for EB-101, its autologous, gene-corrected cell therapy for the treatment of recessive dystrophic epidermolysis bullosa and its lead product candidate, as well as leading pre-commercial planning for its investigational adeno-associated virus vector-based gene therapies.

ShowHide Related Items >><<
GILD Gilead
$75.63 /

-0.84 (-1.10%)

ABEO Abeona Therapeutics
$3.42 /

+0.025 (+0.74%)

ABEO Abeona Therapeutics
$3.42 /

+0.025 (+0.74%)

06/05/20 Cantor Fitzgerald
Abeona could trade higher on Lysogene clinical hold, says Cantor Fitzgerald
05/08/20 Jefferies
Abeona 'one of most underappreciated' in late-stage gene therapy, says Jefferies
12/30/19 H.C. Wainwright
Abeona Therapeutics price target lowered to $11 from $15 at H.C. Wainwright
12/20/19 Cantor Fitzgerald
Abeona financing to lessen takeover chartter, says Cantor Fitzgerald
GILD Gilead
$75.63 /

-0.84 (-1.10%)

06/30/20 SVB Leerink
Gilead's remdesivir price gives confidence in revenue, says SVB Leerink
06/30/20 Wells Fargo
Remdesivir pricing 'a responsible public health decision,' says Wells Fargo
06/29/20 Piper Sandler
Piper says Gilead sale to HHS should make remdesivir opportunity 'more tangible'
06/29/20 RBC Capital
RBC says HIV, other franchises more critical drivers of Gilead than remdesivir
GILD Gilead
$75.63 /

-0.84 (-1.10%)

ABEO Abeona Therapeutics
$3.42 /

+0.025 (+0.74%)

  • 20
    Dec
GILD Gilead
$75.63 /

-0.84 (-1.10%)

GILD Gilead
$75.63 /

-0.84 (-1.10%)

GILD Gilead
$75.63 /

-0.84 (-1.10%)

Conference/Events
International Aids Society to hold a virtual conference » 04:55
07/09/20
07/09
04:55
07/09/20
04:55
ABT

Abbott

$92.57 /

+0.21 (+0.23%)

, BDX

Becton Dickinson

$252.65 /

+1.24 (+0.49%)

, GILD

Gilead

$75.63 /

-0.84 (-1.10%)

, HOLX

Hologic

$57.58 /

+0.72 (+1.27%)

, MRK

Merck

$77.87 /

-0.77 (-0.98%)

, OSUR

OraSure

$13.36 /

+0.37 (+2.85%)

23rd International AIDS…

23rd International AIDS Virtual Conference: AIDS 2020 will be held on July 6-10. Webcast Link

ShowHide Related Items >><<
OSUR OraSure
$13.36 /

+0.37 (+2.85%)

MRK Merck
$77.87 /

-0.77 (-0.98%)

HOLX Hologic
$57.58 /

+0.72 (+1.27%)

GILD Gilead
$75.63 /

-0.84 (-1.10%)

BDX Becton Dickinson
$252.65 /

+1.24 (+0.49%)

ABT Abbott
$92.57 /

+0.21 (+0.23%)

ABT Abbott
$92.57 /

+0.21 (+0.23%)

07/01/20 Lake Street
Lake Street says Tandem pact with Abbott, coverage news both 'very positive'
06/15/20 Piper Sandler
Abbott approval narrows competitive gap to DexCom, says Piper Sandler
06/11/20 UBS
Abbott's COVID-19 testing positive contributor, says UBS
06/09/20 Barrington
Surmodics price target raised to $62 from $56 at Barrington
BDX Becton Dickinson
$252.65 /

+1.24 (+0.49%)

04:47 Today Barclays
Becton Dickinson upgraded to Overweight from Equal Weight at Barclays
07/02/20 Wells Fargo
Becton rallies after Wells says rapid COVID test may come very soon
07/02/20 Wells Fargo
Becton rapid antigen COVID test may be available very soon, says Wells Fargo
06/25/20 Raymond James
Becton Dickinson price target lowered to $265 from $290 at Raymond James
GILD Gilead
$75.63 /

-0.84 (-1.10%)

06/30/20 SVB Leerink
Gilead's remdesivir price gives confidence in revenue, says SVB Leerink
06/30/20 Wells Fargo
Remdesivir pricing 'a responsible public health decision,' says Wells Fargo
06/29/20 Piper Sandler
Piper says Gilead sale to HHS should make remdesivir opportunity 'more tangible'
06/29/20 RBC Capital
RBC says HIV, other franchises more critical drivers of Gilead than remdesivir
HOLX Hologic
$57.58 /

+0.72 (+1.27%)

07/02/20 Needham
Hologic price target raised to $64 from $60 at Needham
06/30/20 Cowen
Hologic helped by COVID testing, Cowen upgrades to Outperform
06/30/20 Cowen
Hologic upgraded to Outperform from Market Perform at Cowen
06/16/20 BTIG
Hologic price target raised to $60 from $54 at BTIG
MRK Merck
$77.87 /

-0.77 (-0.98%)

06/30/20 SVB Leerink
Seattle Genetics price target raised to $167 from $155 at SVB Leerink
06/30/20 Oppenheimer
Seattle Genetics price target raised to $210 from $200 at Oppenheimer
06/25/20 Lake Street
Lake Street says Keytruda approval improves outlook for Checkpoint's cosibelimab
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
OSUR OraSure
$13.36 /

+0.37 (+2.85%)

06/25/20 Lake Street
OraSure initiated with a Buy at Lake Street
04/21/20 Stephens
OraSure resumed with an Equal Weight at Stephens
OSUR OraSure
$13.36 /

+0.37 (+2.85%)

MRK Merck
$77.87 /

-0.77 (-0.98%)

HOLX Hologic
$57.58 /

+0.72 (+1.27%)

GILD Gilead
$75.63 /

-0.84 (-1.10%)

BDX Becton Dickinson
$252.65 /

+1.24 (+0.49%)

ABT Abbott
$92.57 /

+0.21 (+0.23%)

  • 03
    Jun
  • 21
    May
MRK Merck
$77.87 /

-0.77 (-0.98%)

GILD Gilead
$75.63 /

-0.84 (-1.10%)

ABT Abbott
$92.57 /

+0.21 (+0.23%)

OSUR OraSure
$13.36 /

+0.37 (+2.85%)

MRK Merck
$77.87 /

-0.77 (-0.98%)

HOLX Hologic
$57.58 /

+0.72 (+1.27%)

GILD Gilead
$75.63 /

-0.84 (-1.10%)

BDX Becton Dickinson
$252.65 /

+1.24 (+0.49%)

ABT Abbott
$92.57 /

+0.21 (+0.23%)

MRK Merck
$77.87 /

-0.77 (-0.98%)

HOLX Hologic
$57.58 /

+0.72 (+1.27%)

GILD Gilead
$75.63 /

-0.84 (-1.10%)

ABT Abbott
$92.57 /

+0.21 (+0.23%)

Conference/Events
NetApp participates in a conference call hosted by Susquehanna » 04:55
07/09/20
07/09
04:55
07/09/20
04:55
NTAP

NetApp

$43.77 /

+0.92 (+2.15%)

Susquehanna Technology…

Susquehanna Technology Analyst Hosseini holds a conference call with CFO Berry on July 9 at 4 pm.

ShowHide Related Items >><<
NTAP NetApp
$43.77 /

+0.92 (+2.15%)

NTAP NetApp
$43.77 /

+0.92 (+2.15%)

06/26/20
Fly Intel: Top five analyst upgrades
06/26/20 BofA
NetApp upgraded to Buy from Neutral at BofA
06/26/20 BofA
NetApp upgraded to Buy from Neutral at BofA
06/18/20 Deutsche Bank
NetApp initiated with a Hold at Deutsche Bank
NTAP NetApp
$43.77 /

+0.92 (+2.15%)

NTAP NetApp
$43.77 /

+0.92 (+2.15%)

NTAP NetApp
$43.77 /

+0.92 (+2.15%)

NTAP NetApp
$43.77 /

+0.92 (+2.15%)

Yesterday
Hot Stocks
Gilead starts Phase 1a trial of inhaled remdesivir in healthy volunteers » 14:31
07/08/20
07/08
14:31
07/08/20
14:31
GILD

Gilead

$75.11 /

-1.36 (-1.78%)

Gilead Sciences a…

Gilead Sciences a statement from Merdad Parsey, its Chief Medical Officer: "Since the beginning of the COVID-19 pandemic, Gilead has mobilized its deep expertise in virology to rapidly assess the potent investigational antiviral, remdesivir, to evaluate its safety and efficacy as a potential treatment option for patients with COVID-19. With promising data emerging from the randomized, clinical trials of intravenous remdesivir administered to hospitalized patients, it became clear that efforts were needed to investigate the drug's potential in the outpatient setting. Significant research efforts have been undertaken to deliver remdesivir in an inhaled, nebulized format. We are pleased to announce the initiation of a Phase 1a clinical study to evaluate the safety, tolerability and pharmacokinetics of an investigational, inhaled solution of remdesivir in healthy volunteers. Based on current scientific understanding, the upper respiratory tract is the most prevalent site of SARS-CoV-2 infection early in disease. Delivering remdesivir directly to the primary site of infection with a nebulized, inhaled solution may enable more targeted and accessible administration in non-hospitalized patients and potentially lower systemic exposure to the drug. This randomized, placebo-controlled trial will enroll approximately 60 healthy individuals aged 18-45 in the United States to form the basis for further clinical study of the inhaled drug, particularly in patients whose disease has not progressed to require hospitalization."

ShowHide Related Items >><<
GILD Gilead
$75.11 /

-1.36 (-1.78%)

GILD Gilead
$75.11 /

-1.36 (-1.78%)

06/30/20 SVB Leerink
Gilead's remdesivir price gives confidence in revenue, says SVB Leerink
06/30/20 Wells Fargo
Remdesivir pricing 'a responsible public health decision,' says Wells Fargo
06/29/20 Piper Sandler
Piper says Gilead sale to HHS should make remdesivir opportunity 'more tangible'
06/29/20 RBC Capital
RBC says HIV, other franchises more critical drivers of Gilead than remdesivir
GILD Gilead
$75.11 /

-1.36 (-1.78%)

GILD Gilead
$75.11 /

-1.36 (-1.78%)

GILD Gilead
$75.11 /

-1.36 (-1.78%)

GILD Gilead
$75.11 /

-1.36 (-1.78%)

Conference/Events
International Aids Society to hold a virtual conference » 04:55
07/08/20
07/08
04:55
07/08/20
04:55
ABT

Abbott

$92.36 /

-0.62 (-0.67%)

, BDX

Becton Dickinson

$251.41 /

+1.035 (+0.41%)

, GILD

Gilead

$76.47 /

-0.31 (-0.40%)

, HOLX

Hologic

$56.86 /

-0.99 (-1.71%)

, MRK

Merck

$78.64 /

-0.95 (-1.19%)

, OSUR

OraSure

$12.99 /

+0.375 (+2.97%)

23rd International AIDS…

23rd International AIDS Virtual Conference: AIDS 2020 will be held on July 6-10. Webcast Link

ShowHide Related Items >><<
OSUR OraSure
$12.99 /

+0.375 (+2.97%)

MRK Merck
$78.64 /

-0.95 (-1.19%)

HOLX Hologic
$56.86 /

-0.99 (-1.71%)

GILD Gilead
$76.47 /

-0.31 (-0.40%)

BDX Becton Dickinson
$251.41 /

+1.035 (+0.41%)

ABT Abbott
$92.36 /

-0.62 (-0.67%)

ABT Abbott
$92.36 /

-0.62 (-0.67%)

07/01/20 Lake Street
Lake Street says Tandem pact with Abbott, coverage news both 'very positive'
06/15/20 Piper Sandler
Abbott approval narrows competitive gap to DexCom, says Piper Sandler
06/11/20 UBS
Abbott's COVID-19 testing positive contributor, says UBS
06/09/20 Barrington
Surmodics price target raised to $62 from $56 at Barrington
BDX Becton Dickinson
$251.41 /

+1.035 (+0.41%)

07/02/20 Wells Fargo
Becton rallies after Wells says rapid COVID test may come very soon
07/02/20 Wells Fargo
Becton rapid antigen COVID test may be available very soon, says Wells Fargo
06/25/20 Raymond James
Becton Dickinson price target lowered to $265 from $290 at Raymond James
06/01/20
Fly Intel: Top five analyst initiations
GILD Gilead
$76.47 /

-0.31 (-0.40%)

06/30/20 SVB Leerink
Gilead's remdesivir price gives confidence in revenue, says SVB Leerink
06/30/20 Wells Fargo
Remdesivir pricing 'a responsible public health decision,' says Wells Fargo
06/29/20 Piper Sandler
Piper says Gilead sale to HHS should make remdesivir opportunity 'more tangible'
06/29/20 RBC Capital
RBC says HIV, other franchises more critical drivers of Gilead than remdesivir
HOLX Hologic
$56.86 /

-0.99 (-1.71%)

07/02/20 Needham
Hologic price target raised to $64 from $60 at Needham
06/30/20 Cowen
Hologic helped by COVID testing, Cowen upgrades to Outperform
06/30/20 Cowen
Hologic upgraded to Outperform from Market Perform at Cowen
06/16/20 BTIG
Hologic price target raised to $60 from $54 at BTIG
MRK Merck
$78.64 /

-0.95 (-1.19%)

06/30/20 SVB Leerink
Seattle Genetics price target raised to $167 from $155 at SVB Leerink
06/30/20 Oppenheimer
Seattle Genetics price target raised to $210 from $200 at Oppenheimer
06/25/20 Lake Street
Lake Street says Keytruda approval improves outlook for Checkpoint's cosibelimab
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
OSUR OraSure
$12.99 /

+0.375 (+2.97%)

06/25/20 Lake Street
OraSure initiated with a Buy at Lake Street
04/21/20 Stephens
OraSure resumed with an Equal Weight at Stephens
OSUR OraSure
$12.99 /

+0.375 (+2.97%)

MRK Merck
$78.64 /

-0.95 (-1.19%)

HOLX Hologic
$56.86 /

-0.99 (-1.71%)

GILD Gilead
$76.47 /

-0.31 (-0.40%)

BDX Becton Dickinson
$251.41 /

+1.035 (+0.41%)

ABT Abbott
$92.36 /

-0.62 (-0.67%)

  • 03
    Jun
  • 21
    May
MRK Merck
$78.64 /

-0.95 (-1.19%)

GILD Gilead
$76.47 /

-0.31 (-0.40%)

ABT Abbott
$92.36 /

-0.62 (-0.67%)

OSUR OraSure
$12.99 /

+0.375 (+2.97%)

MRK Merck
$78.64 /

-0.95 (-1.19%)

HOLX Hologic
$56.86 /

-0.99 (-1.71%)

GILD Gilead
$76.47 /

-0.31 (-0.40%)

BDX Becton Dickinson
$251.41 /

+1.035 (+0.41%)

ABT Abbott
$92.36 /

-0.62 (-0.67%)

MRK Merck
$78.64 /

-0.95 (-1.19%)

HOLX Hologic
$56.86 /

-0.99 (-1.71%)

GILD Gilead
$76.47 /

-0.31 (-0.40%)

ABT Abbott
$92.36 /

-0.62 (-0.67%)

Tuesday
Hot Stocks
Arcus Biosciences names Bob Goeltz CFO » 16:11
07/07/20
07/07
16:11
07/07/20
16:11
RCUS

Arcus Biosciences

$25.30 /

+1.26 (+5.24%)

, UBX

Unity Biotechnology

$8.10 /

-0.77 (-8.68%)

, CTMX

CytomX Therapeutics

$8.22 /

+0.04 (+0.49%)

, GILD

Gilead

$76.40 /

-0.385 (-0.50%)

Arcus Biosciences (RCUS)…

Arcus Biosciences (RCUS) announced that Bob Goeltz will join Arcus as Chief Financial Officer on August 1, 2020. Goeltz most recently served as Chief Financial Officer and Senior Vice President of UNITY Biotechnology (UBX) and immediately before that as Chief Financial Officer of CytomX Therapeutics (CTMX). "Following the recent announcement of our 10-year collaboration with Gilead (GILD) and successful $348 million financial offering, combined with our growing portfolio of programs, I am confident Bob will play an integral role in advancing Arcus through our next phase of growth towards commercialization and beyond," said Terry Rosen, Ph.D., Chief Executive Officer of Arcus. "Bob's experience in navigating the strategic and operational decisions necessary to transition the opportunities derived from an intense, deep and innovative R&D effort through the commercialization process to broadly benefit patients will be central to Arcus's future success. With the potential to have three molecules in registrational studies in 2021, a prolific discovery team and a uniquely enabling and nascent alliance with Gilead, Bob joins Arcus at a seminal inflection point, with the opportunity to make Arcus's vision of creating, developing and commercializing innovative and curative therapies for cancer a reality."

ShowHide Related Items >><<
UBX Unity Biotechnology
$8.10 /

-0.77 (-8.68%)

RCUS Arcus Biosciences
$25.30 /

+1.26 (+5.24%)

GILD Gilead
$76.40 /

-0.385 (-0.50%)

CTMX CytomX Therapeutics
$8.22 /

+0.04 (+0.49%)

RCUS Arcus Biosciences
$25.30 /

+1.26 (+5.24%)

06/10/20 SunTrust
Arcus Biosciences price target raised to $45 from $22 at SunTrust
06/03/20 SVB Leerink
Gilead upgraded to Outperform at SVB Leerink on remdesivir sales, Arcus deal
06/02/20 Citi
Arcus Biosciences price target raised to $41 from $15 at Citi
05/27/20 Raymond James
Raymond James keeps Market Perform on Gilead following Arcus partnership
UBX Unity Biotechnology
$8.10 /

-0.77 (-8.68%)

12/13/19
Unity Biotechnology management to meet with Mizuho
12/12/19 Cantor Fitzgerald
Unity Biotechnology assumed with an Overweight at Cantor Fitzgerald
CTMX CytomX Therapeutics
$8.22 /

+0.04 (+0.49%)

06/01/20 Jefferies
Jefferies 'underwhelmed' by CytomX presentations at ASCO, downgrades to Hold
06/01/20 Jefferies
CytomX Therapeutics downgraded to Hold from Buy at Jefferies
05/29/20 Piper Sandler
CytomX ASCO data sets point torwards Probody validation, says Piper Sandler
05/14/20 H.C. Wainwright
CytomX Therapeutics price target lowered to $12 from $16 at H.C. Wainwright
GILD Gilead
$76.40 /

-0.385 (-0.50%)

06/30/20 SVB Leerink
Gilead's remdesivir price gives confidence in revenue, says SVB Leerink
06/30/20 Wells Fargo
Remdesivir pricing 'a responsible public health decision,' says Wells Fargo
06/29/20 Piper Sandler
Piper says Gilead sale to HHS should make remdesivir opportunity 'more tangible'
06/29/20 RBC Capital
RBC says HIV, other franchises more critical drivers of Gilead than remdesivir
UBX Unity Biotechnology
$8.10 /

-0.77 (-8.68%)

RCUS Arcus Biosciences
$25.30 /

+1.26 (+5.24%)

GILD Gilead
$76.40 /

-0.385 (-0.50%)

CTMX CytomX Therapeutics
$8.22 /

+0.04 (+0.49%)

  • 29
    May
RCUS Arcus Biosciences
$25.30 /

+1.26 (+5.24%)

GILD Gilead
$76.40 /

-0.385 (-0.50%)

RCUS Arcus Biosciences
$25.30 /

+1.26 (+5.24%)

GILD Gilead
$76.40 /

-0.385 (-0.50%)

CTMX CytomX Therapeutics
$8.22 /

+0.04 (+0.49%)

RCUS Arcus Biosciences
$25.30 /

+1.26 (+5.24%)

GILD Gilead
$76.40 /

-0.385 (-0.50%)

Conference/Events
FBN Securities network security analyst to hold analyst/industry conference call » 11:25
07/07/20
07/07
11:25
07/07/20
11:25
PANW

Palo Alto Networks

$238.05 /

+2.24 (+0.95%)

, ZS

Zscaler

$115.50 /

+0.74 (+0.64%)

, FTNT

Fortinet

$138.85 /

-0.76 (-0.54%)

, CHKP

Check Point

$114.66 /

+3.2 (+2.87%)

, FEYE

FireEye

$12.25 /

-0.005 (-0.04%)

, PFPT

Proofpoint

$113.11 /

-0.44 (-0.39%)

, OKTA

Okta

$209.33 /

+2.3 (+1.11%)

, CSCO

Cisco

$45.97 /

-0.455 (-0.98%)

, PSTG

Pure Storage

$17.65 /

-0.02 (-0.11%)

, NTNX

Nutanix

$23.55 /

-0.04 (-0.17%)

, NTAP

NetApp

$43.35 /

-1.75 (-3.88%)

, VMW

VMware

$148.25 /

-0.91 (-0.61%)

, CTXS

Citrix

$152.27 /

+2.01 (+1.34%)

Network Security…

Network Security Analysts, along with Jim Gruzlewski, a professional in the security space, discusses channel perspective and provides good channel knowledge on companies in storage and software on an Analyst/Industry conference call to be held on July 7 at 12 pm.

ShowHide Related Items >><<
ZS Zscaler
$115.50 /

+0.74 (+0.64%)

VMW VMware
$148.25 /

-0.91 (-0.61%)

PSTG Pure Storage
$17.65 /

-0.02 (-0.11%)

PFPT Proofpoint
$113.11 /

-0.44 (-0.39%)

PANW Palo Alto Networks
$238.05 /

+2.24 (+0.95%)

OKTA Okta
$209.33 /

+2.3 (+1.11%)

NTNX Nutanix
$23.55 /

-0.04 (-0.17%)

NTAP NetApp
$43.35 /

-1.75 (-3.88%)

FTNT Fortinet
$138.85 /

-0.76 (-0.54%)

FEYE FireEye
$12.25 /

-0.005 (-0.04%)

CTXS Citrix
$152.27 /

+2.01 (+1.34%)

CSCO Cisco
$45.97 /

-0.455 (-0.98%)

CHKP Check Point
$114.66 /

+3.2 (+2.87%)

PANW Palo Alto Networks
$238.05 /

+2.24 (+0.95%)

06/04/20 Cleveland Research
Palo Alto momentum extending into Q4, says Cleveland Research
05/22/20 BMO Capital
Palo Alto Networks price target raised to $260 from $230 at BMO Capital
05/22/20 RBC Capital
Palo Alto Networks price target raised to $248 from $225 at RBC Capital
05/22/20 Northland
Palo Alto Networks price target raised to $285 from $274 at Northland
ZS Zscaler
$115.50 /

+0.74 (+0.64%)

07/07/20 Rosenblatt
Zscaler price target raised to $135 from $115 at Rosenblatt
07/06/20 RBC Capital
Zscaler initiated with an Outperform at RBC Capital
06/22/20 Needham
Zscaler price target raised to $130 from $110 at Needham
06/18/20 Morgan Stanley
Morgan Stanley ups Cloudflare to Equal Weight on security architecture changes
FTNT Fortinet
$138.85 /

-0.76 (-0.54%)

07/07/20 JPMorgan
Fortinet downgraded to Neutral with $135 target at JPMorgan
07/07/20 JPMorgan
Fortinet downgraded to Neutral from Overweight at JPMorgan
06/16/20 Piper Sandler
Fortinet price target raised to $146 from $125 at Piper Sandler
06/03/20 Wedbush
Fortinet price target raised to $170 from $150 at Wedbush
CHKP Check Point
$114.66 /

+3.2 (+2.87%)

05/04/20 Evercore ISI
Check Point initiated with an In Line at Evercore ISI
04/28/20 Wells Fargo
Check Point price target raised to $110 from $105 at Wells Fargo
04/28/20 Jefferies
Check Point price target raised to $110 from $100 at Jefferies
04/06/20 OTR Global
Check Point upgraded to Mixed from Negative at OTR Global
FEYE FireEye
$12.25 /

-0.005 (-0.04%)

04/13/20 BMO Capital
FireEye price target lowered to $12.50 from $17 at BMO Capital
03/05/20
Fly Intel: Top five analyst upgrades
03/05/20 Goldman Sachs
Goldman upgrades FireEye to Buy, sees 33% upside in the shares
03/05/20 Goldman Sachs
FireEye upgraded to Buy from Neutral at Goldman Sachs
PFPT Proofpoint
$113.11 /

-0.44 (-0.39%)

05/08/20 BTIG
Proofpoint price target raised to $151 from $125 at BTIG
04/08/20 DA Davidson
DA Davidson says Proofpoint, SailPoint have strongest pipelines in sector
03/27/20 BTIG
Proofpoint assumed with a Buy at BTIG
03/24/20 Goldman Sachs
Goldman Sachs starts Rapid7, Tenable Holdings at Buy, SailPoint at Sell
OKTA Okta
$209.33 /

+2.3 (+1.11%)

07/06/20
Fly Intel: Top five analyst initiations
07/06/20 RBC Capital
Okta initiated with an Outperform at RBC Capital
06/29/20 BTIG
Okta downgraded to Neutral from Buy at BTIG
06/24/20 Baird
Ping Identity initiated with a Neutral at Baird
CSCO Cisco
$45.97 /

-0.455 (-0.98%)

07/02/20 JPMorgan
JPMorgan sees attractive opportunities in India for Cisco, Ciena
06/16/20
Fly Intel: Top five analyst upgrades
06/16/20 BofA
Cisco upgraded to Buy from Neutral at BofA
06/16/20 BofA
Cisco upgraded to Buy from Neutral at BofA
PSTG Pure Storage
$17.65 /

-0.02 (-0.11%)

06/18/20 Deutsche Bank
Pure Storage initiated with a Hold at Deutsche Bank
06/17/20 Deutsche Bank
Pure Storage initiated with a Hold at Deutsche Bank
05/29/20 Lake Street
Pure Storage a share gainer with 'robust' subscription growth, says Lake Street
05/29/20 Northland
Pure Storage price target raised to $23 from $21 at Northland
NTNX Nutanix
$23.55 /

-0.04 (-0.17%)

05/28/20 RBC Capital
Nutanix price target raised to $27 from $23 at RBC Capital
05/28/20 Wells Fargo
Nutanix price target raised to $27 from $22 at Wells Fargo
05/28/20 JMP Securities
Nutanix price target lowered to $45 from $52 at JMP Securities
05/21/20 JPMorgan
Nutanix price target lowered to $24 from $27 at JPMorgan
NTAP NetApp
$43.35 /

-1.75 (-3.88%)

06/26/20
Fly Intel: Top five analyst upgrades
06/26/20 BofA
NetApp upgraded to Buy from Neutral at BofA
06/26/20 BofA
NetApp upgraded to Buy from Neutral at BofA
06/18/20 Deutsche Bank
NetApp initiated with a Hold at Deutsche Bank
VMW VMware
$148.25 /

-0.91 (-0.61%)

07/07/20 Deutsche Bank
Dell offers 20%-30% upside on standalone basis, says Deutsche Bank
06/24/20 Bernstein
Potential spinoff would be largely positive for VMware, says Bernstein
06/24/20
Fly Intel: Top five analyst upgrades
06/24/20 Wells Fargo
Dell Technologies price target raised to $70 from $57 at Wells Fargo
CTXS Citrix
$152.27 /

+2.01 (+1.34%)

06/24/20 Goldman Sachs
Citrix price target raised to $172 from $154 at Goldman Sachs
04/24/20 Wells Fargo
Citrix price target raised to $165 from $150 at Wells Fargo
04/24/20 Deutsche Bank
Citrix price target raised to $200 from $175 at Deutsche Bank
04/24/20 Morgan Stanley
Citrix price target raised to $165 from $160 at Morgan Stanley
ZS Zscaler
$115.50 /

+0.74 (+0.64%)

VMW VMware
$148.25 /

-0.91 (-0.61%)

PSTG Pure Storage
$17.65 /

-0.02 (-0.11%)

PFPT Proofpoint
$113.11 /

-0.44 (-0.39%)

PANW Palo Alto Networks
$238.05 /

+2.24 (+0.95%)

OKTA Okta
$209.33 /

+2.3 (+1.11%)

NTNX Nutanix
$23.55 /

-0.04 (-0.17%)

NTAP NetApp
$43.35 /

-1.75 (-3.88%)

FTNT Fortinet
$138.85 /

-0.76 (-0.54%)

FEYE FireEye
$12.25 /

-0.005 (-0.04%)

CTXS Citrix
$152.27 /

+2.01 (+1.34%)

CSCO Cisco
$45.97 /

-0.455 (-0.98%)

CHKP Check Point
$114.66 /

+3.2 (+2.87%)

ZS Zscaler
$115.50 /

+0.74 (+0.64%)

VMW VMware
$148.25 /

-0.91 (-0.61%)

PANW Palo Alto Networks
$238.05 /

+2.24 (+0.95%)

NTNX Nutanix
$23.55 /

-0.04 (-0.17%)

NTAP NetApp
$43.35 /

-1.75 (-3.88%)

FEYE FireEye
$12.25 /

-0.005 (-0.04%)

CSCO Cisco
$45.97 /

-0.455 (-0.98%)

ZS Zscaler
$115.50 /

+0.74 (+0.64%)

VMW VMware
$148.25 /

-0.91 (-0.61%)

PSTG Pure Storage
$17.65 /

-0.02 (-0.11%)

PANW Palo Alto Networks
$238.05 /

+2.24 (+0.95%)

OKTA Okta
$209.33 /

+2.3 (+1.11%)

NTNX Nutanix
$23.55 /

-0.04 (-0.17%)

NTAP NetApp
$43.35 /

-1.75 (-3.88%)

FTNT Fortinet
$138.85 /

-0.76 (-0.54%)

FEYE FireEye
$12.25 /

-0.005 (-0.04%)

CTXS Citrix
$152.27 /

+2.01 (+1.34%)

CSCO Cisco
$45.97 /

-0.455 (-0.98%)

CHKP Check Point
$114.66 /

+3.2 (+2.87%)

ZS Zscaler
$115.50 /

+0.74 (+0.64%)

VMW VMware
$148.25 /

-0.91 (-0.61%)

PSTG Pure Storage
$17.65 /

-0.02 (-0.11%)

PANW Palo Alto Networks
$238.05 /

+2.24 (+0.95%)

OKTA Okta
$209.33 /

+2.3 (+1.11%)

NTNX Nutanix
$23.55 /

-0.04 (-0.17%)

NTAP NetApp
$43.35 /

-1.75 (-3.88%)

FTNT Fortinet
$138.85 /

-0.76 (-0.54%)

FEYE FireEye
$12.25 /

-0.005 (-0.04%)

CTXS Citrix
$152.27 /

+2.01 (+1.34%)

CSCO Cisco
$45.97 /

-0.455 (-0.98%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.